NCT07262320 Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America
| NCT ID | NCT07262320 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alabama at Birmingham |
| Condition | Dialysis |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2026-03-01 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2026-03-01 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an international, multicenter, observational study aimed at investigating acute kidney injury requiring renal replacement therapy (AKI-RRT) in Latin American countries. The main questions this study aims to answer are: * What is the epidemiology, outcomes, and processes of care for patients with AKI-RRT in Latin America? * How do outcomes differ across different countries in Latin America? * What factors (demographics, clinical, socioeconomic) influence outcomes in patients with AKI-RRT in Latin America? The main aims of this study are to: * Establish a comprehensive database containing clinical, laboratory, treatment, process, and outcome data of patients with AKI-RRT in Latin America * Describe current epidemiology of AKI-RRT in Latin America * Compare processes of care and outcomes across different countries in Latin America * Provide data resources to facilitate and promote clinical research in AKI-RRT
Eligibility Criteria
Inclusion Criteria: * Adult patient (≥18) admitted to the ICU * First ICU admission during current hospitalization * Diagnosis of acute kidney injury stage 3 according to KDIGO guidelines * RRT initiated no earlier than 3 days before or no later than 7 days after ICU admission Exclusion Criteria: * Transfer from outside hospital with ongoing RRT * RRT exposure of less than 2 days (if CRRT or PD was provided) or less than 2 HD/SLED sessions * Kidney failure (ESRD) patients on maintenance dialysis * Kidney transplant recipients * Previous or new diagnosis of glomerulonephritis
Contact & Investigator
Javier A Neyra, MD, MSCS
PRINCIPAL INVESTIGATOR
University of Alabama at Birmingham
Frequently Asked Questions
Who can join the NCT07262320 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dialysis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07262320 currently recruiting?
Yes, NCT07262320 is actively recruiting participants. Contact the research team at jneyra@uabmc.edu for enrollment information.
Where is the NCT07262320 trial being conducted?
This trial is being conducted at Cochabamba, Bolivia, Bahia, Brazil, Porto Alegre, Brazil, São Paulo, Brazil and 11 additional locations.
Who is sponsoring the NCT07262320 clinical trial?
NCT07262320 is sponsored by University of Alabama at Birmingham. The principal investigator is Javier A Neyra, MD, MSCS at University of Alabama at Birmingham. The trial plans to enroll 1,000 participants.